|
![]() |
|||
|
||||
OverviewDisorders of Protein Synthesis, Volume 132 in the Advances in Protein Chemistry and Structural Biology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Full Product DetailsAuthor: Rossen Donev (Head of Research, MicroPharm Limited, UK)Publisher: Elsevier Science & Technology Imprint: Academic Press Inc Weight: 0.590kg ISBN: 9780323997805ISBN 10: 0323997805 Pages: 290 Publication Date: 07 September 2022 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsContributors in this volume include: Alessio Branchini Fabio Di Domenico Baris Akinci Asim Kanti Duttaroy Qiaozhu Su Maria I. Vaccaro Nicola Luigi Bragazzi Chandrabose Selvaraj Nicola Luigi Bragazzi C. George Priya Doss C. George Priya Doss Víctor García-González Mojgan RastegarReviewsAuthor InformationRossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications. Tab Content 6Author Website:Countries AvailableAll regions |